Hawi Amale 4
4 · PENWEST PHARMACEUTICALS CO · Filed Apr 29, 2010
Insider Transaction Report
Form 4
Hawi Amale
SVP, Pharmaceutical Dev.
Transactions
- Exercise/Conversion
Common stock
2010-04-28$1.56/sh+6,500$10,140→ 6,500 total - Exercise/Conversion
Stock Option (Right-to-Buy)
2010-04-28−6,500→ 58,500 totalExercise: $1.56From: 2010-03-05Exp: 2019-03-05→ Common Stock (6,500 underlying)